* Cardlytics Inc CDLX.OQ reported a quarterly adjusted
loss
of 29 cents per share for the quarter ended in December. The
mean expectation of six analysts for the quarter was for a loss
of 46 cents per share.
* Revenue fell 8.4% to $82.50 million from a year ago;
analysts
expected $83.54 million.
* Cardlytics Inc's reported EPS for the quarter was a loss
of
$11.32.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Cardlytics Inc shares had fallen by 5.7% this quarter.
* The company reported a quarterly loss of $378.28 million.
* Wall Street's median 12-month price target for Cardlytics
Inc is
$7.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
This summary was machine generated from Refinitiv data March 1
at 10:55 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.46 -0.29 Beat
Sep. 30 2022 -0.57 -0.50 Beat
Jun. 30 2022 -0.47 -0.65 Missed
Mar. 31 2022 -0.55 -0.38 Beat